psilocin has been researched along with Electrocardiogram QT Prolonged in 1 studies
psilocin: psilocybine minus the phosphate ester; RN given refers to parent cpd; structure
psilocin : A tryptamine alkaloid that is N,N-dimethyltryptamine carrying an additional hydroxy substituent at position 4. A hallucinogenic alkaloid isolated in trace amounts from Psilocybe mushrooms (also known as Teonanacatl or "magic mushrooms").
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Dahmane, E | 1 |
Hutson, PR | 1 |
Gobburu, JVS | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
A Phase 1, Two-Part Study in Healthy Volunteers to Evaluate The Effect of Psilocybin on Cardiac Repolarization and The Effect of Food on Psilocybin Pharmacokinetics[NCT05478278] | Phase 1 | 60 participants (Actual) | Interventional | 2022-06-22 | Completed | ||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
1 trial available for psilocin and Electrocardiogram QT Prolonged
Article | Year |
---|---|
Exposure-Response Analysis to Assess the Concentration-QTc Relationship of Psilocybin/Psilocin.
Topics: Adult; Dose-Response Relationship, Drug; Electrocardiography; Female; Hallucinogens; Healthy Volunte | 2021 |